LeafNLP Demos
Back to explore

Report #2885624

Received Feb 16, 2026

Reports are unverified and do not show that a vaccine caused an event. Full disclaimer

Overview

Sex
Female
Age
55 yrs
State
PA
Recovered
Unknown
Vaccinated
Feb 11, 2026
Onset
Feb 11, 2026
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
MMRMEASLES + MUMPS + RUBELLA (PRIORIX)GLAXOSMITHKLINE BIOLOGICALSUNK—IM

Symptoms (1)

Incorrect route of product administration

Symptom narrative

a 55 years old patient may received a Priorix intramuscular, instead of subcutaneous.; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of subcutaneous injection formulation administered by other route in a 55-year-old female patient who received MMR (Priorix) for prophylaxis. On 11-FEB-2026, the patient received Priorix (intramuscular). On 11-FEB-2026, an unknown time after receiving Priorix, the patient experienced subcutaneous injection formulation administered by other route (Verbatim: a 55 years old patient may received a Priorix intramuscular, instead of subcutaneous.). The outcome of the subcutaneous injection formulation administered by other route was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 11-FEB-2026 The batch number was not provided upon follow up with the reporter.